Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v9-EN
Language French English
Date Updated 2020-02-15 2020-02-15
Drug Identification Number 02242527 02242527
Brand name SANDOZ PROCTOMYXIN HC SANDOZ PROCTOMYXIN HC
Common or Proper name PROCTOMYXIN PROCTOMYXIN
Company Name ODAN LABORATORIES LTD ODAN LABORATORIES LTD
Ingredients DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN DIBUCAINE HYDROCHLORIDE HYDROCORTISONE FRAMYCETIN SULFATE ESCULIN
Strength(s) 5MG 5MG 10MG 10MG 5MG 5MG 10MG 10MG
Dosage form(s) OINTMENT OINTMENT
Route of administration RECTAL RECTAL
Packaging size 15G 15G
ATC code C05AA C05AA
ATC description AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2019-07-03 2019-07-03
Estimated end date 2020-01-31 2020-01-31
Actual end date 2020-01-20 2020-01-20
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments